Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Government Reform
Format:	Government Document Book
Language:	English
Published:	Washington : U.S. G.P.O. : 2005.
Subjects:	Nonsteroidal anti-inflammatory agents > United States > Testing. Nonsteroidal anti-inflammatory agents > Safety regulations > United States. Drugs > United States > Testing. Drugs > Safety regulations > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS63169 Errata

Description
Item Description:	Distributed to some depository libraries in microfiche. Shipping list number not available. Printed record lacks prepared statement of Rep. Charles W. Dent. "Serial number 109-27."
Physical Description:	iii, 140 pages : illustrations ; 24 cm. Also available via Internet from the GPO Access web site. Addresses as of 11/15/05: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_house_hearings&docid=f:21483.wais (text version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fhouse%5Fhearings&docid=f:21483.pdf (PDF version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_house_hearings&docid=f:22684.wais (errata, text version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fhouse%5Fhearings&docid=f:22684.pdf (errata, PDF version); current access available via PURLs.
Bibliography:	Includes bibliographical references.
ISBN:	0160749336